受强制性开放获取政策约束的文章 - Neil Fleshner了解详情
整体PCCCIHRCCSNIHOICRCancer Research UKNSERCNIHRFCTMRCHSFDoDFRQSDFGVAGenome CanadaProstate Cancer UKWellcomeHHMINHMRCEuropean CommissionSCFKWFNSFDOEHRBSFINWOSwedish Research CouncilVersus Arthritis, UKYorkshire Cancer Research, UKDoris Duke Charitable FoundationGovernment of SpainPCORINMRCGovernment of ItalyAIRC Foundation for Cancer Research in ItalySusan G. Komen
无法在其他位置公开访问的文章:34 篇
Active surveillance magnetic resonance imaging study (ASIST): results of a randomized multicenter prospective trial
L Klotz, A Loblaw, L Sugar, M Moussa, DM Berman, T Van der Kwast, ...
European Urology 75 (2), 300-309, 2019
强制性开放获取政策: Ontario Institute for Cancer Research
Prehabilitation for radical prostatectomy: a multicentre randomized controlled trial
D Santa Mina, WJ Hilton, AG Matthew, R Awasthi, G Bousquet-Dion, ...
Surgical oncology 27 (2), 289-298, 2018
强制性开放获取政策: Prostate Cancer Canada
Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data set
M Masoomian, MR Downes, J Sweet, C Cheung, AJ Evans, N Fleshner, ...
Histopathology 74 (3), 474-482, 2019
强制性开放获取政策: Prostate Cancer Canada
Urinary DNA methylation biomarkers for noninvasive prediction of aggressive disease in patients with prostate cancer on active surveillance
F Zhao, E Olkhov-Mitsel, T van der Kwast, J Sykes, D Zdravic, ...
The Journal of urology 197 (2), 335-341, 2017
强制性开放获取政策: Prostate Cancer Canada
Varied definitions of hospital volume did not alter the conclusions of volume–outcome analyses
GS Kulkarni, A Laupacis, DR Urbach, NE Fleshner, PC Austin
Journal of clinical epidemiology 62 (4), 400-407, 2009
强制性开放获取政策: Canadian Institutes of Health Research
A phase II, randomized, open-label study of neoadjuvant degarelix versus LHRH agonist in prostate cancer patients prior to radical prostatectomy
RK Sayyid, A Evans, K Hersey, R Maloni, A Hurtado-Coll, G Kulkarni, ...
Clinical Cancer Research 23 (8), 1974-1980, 2017
强制性开放获取政策: Canadian Cancer Society, Prostate Cancer Canada
miRNAs dysregulated in association with Gleason grade regulate extracellular matrix, cytoskeleton and androgen receptor pathways
Z Lichner, Q Ding, S Samaan, C Saleh, A Nasser, S Al‐Haddad, ...
The Journal of pathology 237 (2), 226-237, 2015
强制性开放获取政策: Canadian Institutes of Health Research, Prostate Cancer Canada
FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer
Y Neuzillet, BWG van Rhijn, NL Prigoda, B Bapat, L Liu, PJ Bostrom, ...
Virchows Archiv 465, 207-213, 2014
强制性开放获取政策: Dutch Cancer Society
Metformin elicits antitumor effects and downregulates the histone methyltransferase multiple myeloma SET domain (MMSET) in prostate cancer cells
NMA White‐Al Habeeb, J Garcia, N Fleshner, B Bapat
The Prostate 76 (16), 1507-1518, 2016
强制性开放获取政策: Canadian Cancer Society, Canadian Institutes of Health Research, Prostate …
Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy
D Deniffel, N Perlis, S Ghai, S Girgis, GM Healy, N Fleshner, R Hamilton, ...
European Radiology 32 (11), 7544-7554, 2022
强制性开放获取政策: German Research Foundation, Ontario Institute for Cancer Research
The impact of diet and micronutrient supplements on the expression of neuroendocrine markers in murine Lady transgenic prostate
J Palmer, V Venkateswaran, NE Fleshner, LH Klotz, ME Cox
The Prostate 68 (4), 345-353, 2008
强制性开放获取政策: Canadian Institutes of Health Research
Does the visibility of grade group 1 prostate cancer on baseline multiparametric magnetic resonance imaging impact clinical outcomes?
D Deniffel, E Salinas, M Ientilucci, AJ Evans, N Fleshner, S Ghai, ...
The Journal of Urology 204 (6), 1187-1194, 2020
强制性开放获取政策: German Research Foundation, Ontario Institute for Cancer Research
An integrative DNA methylation model for improved prognostication of postsurgery recurrence and therapy in prostate cancer patients
R Jeyapala, S Kamdar, E Olkhov-Mitsel, AJ Savio, F Zhao, C Cuizon, ...
Urologic Oncology: Seminars and Original Investigations 38 (2), 39. e1-39. e9, 2020
强制性开放获取政策: Prostate Cancer Canada
A phase 1 pilot study of preoperative radiation therapy for prostate cancer: Long-term toxicity and oncologic outcomes
R Glicksman, N Sanmamed, J Thoms, AR Zlotta, A Finelli, ...
International Journal of Radiation Oncology* Biology* Physics 104 (1), 61-66, 2019
强制性开放获取政策: US Department of Defense, Canadian Cancer Society, Prostate Cancer Canada
GBX2 methylation is a novel prognostic biomarker and improves prediction of biochemical recurrence among patients with prostate cancer negative for intraductal carcinoma and …
R Jeyapala, AJ Savio, E Olkhov-Mitsel, S Kamdar, F Zhao, C Cuizon, ...
European urology oncology 2 (3), 231-238, 2019
强制性开放获取政策: Prostate Cancer Canada
Statin use and time to progression in men on active surveillance for prostate cancer
VH Jayalath, M Nayan, A Finelli, M Komisarenki, N Timilshina, ...
Prostate cancer and prostatic diseases 21 (4), 509-515, 2018
强制性开放获取政策: Canadian Cancer Society, Prostate Cancer Canada
UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways
L Lacombe, H Hovington, H Brisson, S Mehdi, D Beillevaire, JP Émond, ...
Cancer Letters 553, 215994, 2023
强制性开放获取政策: US National Institutes of Health, Canadian Institutes of Health Research …
Benefit of a more extended pelvic lymph node dissection among patients undergoing radical prostatectomy for localized prostate cancer: A causal mediation analysis
MS Wettstein, LA David, C Pazhepurackel, AA Qureshi, A Zisman, ...
The Prostate 81 (5), 286-294, 2021
强制性开放获取政策: Swiss Cancer Foundation
Molecular profiling of ETS gene rearrangements in patients with prostate cancer registered in REDEEM clinical trial
N Palanisamy, A Tsodikov, W Yan, K Suleman, R Rittmaster, SM Lucia, ...
Urologic Oncology: Seminars and Original Investigations 33 (3), 108. e5-108. e13, 2015
强制性开放获取政策: Howard Hughes Medical Institute, Doris Duke Charitable Foundation
Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial
NE Fleshner, RK Sayyid, AR Hansen, JLK Chin, R Fernandes, E Winquist, ...
Clinical Cancer Research 29 (19), 3867-3874, 2023
强制性开放获取政策: Ontario Institute for Cancer Research
出版信息和资助信息由计算机程序自动确定